Genzyme Honors Innovation in Gaucher Disease Research through Its...

"Development of an induced pluripotent stem cell model of neuronopathic Gaucher's Disease for investigating mechanisms of pathogenesis and small molecule testing." Genzyme's Gaucher Generation program provides funding to researchers throughout the world to stimulate and support the advancement of medical knowledge in Gaucher disease.

http://eon.businesswire.com/news/eon/20121126005701/en/Genzyme-Honors-Innovation-Gaucher-Disease-Research-2012